BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11910687)

  • 1. [Basis and guidelines for empirical antibody therapy in the management of community-acquired pneumonia].
    Louzir B; Beji M; Fajraoui N; Mehiri N; Daghfous J
    Tunis Med; 2001 Oct; 79(10):491-7. PubMed ID: 11910687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial therapy of pneumonia in infants and children.
    Harris JA
    Semin Respir Infect; 1996 Sep; 11(3):139-47. PubMed ID: 8883171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired pneumonia in adults.
    Sue DY
    West J Med; 1994 Oct; 161(4):383-9. PubMed ID: 7817549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of community-acquired pneumonia treated at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W; Tantiwong P
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):355-61. PubMed ID: 12236437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is new in the treatment of community-acquired pneumonia?].
    Welte T; Marre R; Suttorp N;
    Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-acquired pneumonia in adults: initial antibiotic therapy.
    King DE; Pippin HJ
    Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two guidelines on community-acquired pneumonia: both an important basis for individual policies].
    van den Broek PJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2492-4. PubMed ID: 16304885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].
    Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe community-acquired pneumonia].
    Leroy O
    Rev Prat; 2001 Mar; 51(6):614-9. PubMed ID: 11345862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correct approach to community-acquired pneumonia in immunocompetent adults: review of current guidelines.
    Carbonara S; Stano F; Scotto G; Monno L; Angarano G
    New Microbiol; 2008 Jan; 31(1):1-18. PubMed ID: 18437837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
    File TM; Benninger MS; Jacobs MR
    Clin Lab Med; 2004 Jun; 24(2):531-51. PubMed ID: 15177852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe community-acquired pneumonia: an Australian perspective.
    Wilson PA; Ferguson J
    Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and therapy of community-acquired pneumonia].
    Speich R; Ruef C; Russi EW
    Schweiz Med Wochenschr; 1993 Oct; 123(39):1846-56. PubMed ID: 8211038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.
    Rosón B; Carratalà J; Fernández-Sabé N; Tubau F; Manresa F; Gudiol F
    Arch Intern Med; 2004 Mar; 164(5):502-8. PubMed ID: 15006826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Agreement between clinical practice guidelines for management of community-acquired pneumonia. A retrospective study of 101 hospitalized patients].
    Labarère J; Fourny M; Pavese P; Bedouch P; Brambilla C; François P
    Rev Mal Respir; 2003 Dec; 20(6 Pt 1):858-70. PubMed ID: 14743087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.
    Carratalà J; Mykietiuk A; Fernández-Sabé N; Suárez C; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Arch Intern Med; 2007 Jul; 167(13):1393-9. PubMed ID: 17620533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of community-acquired pneumonia.
    Johnson M
    Iowa Med; 1993 Sep; 83(9):339-42. PubMed ID: 8300373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia.
    Daneman N; Low DE; McGeer A; Green KA; Fisman DN
    Clin Infect Dis; 2008 Apr; 46(8):1131-8. PubMed ID: 18444846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.